Roche CEO laments Swiss franc strength as drugmaker doubles down on U.S. investment

3 hours ago

Roche reported falling sales in the first three months of the year, as the strength of the Swiss franc and generic competition for some of its older …

Read Entire Article

Roche CEO laments Swiss franc strength as drugmaker doubles down on U.S. investment

Related

Tom Lee's Bitmine Adds 101,627 ETH Worth $233 Million in Its...

Shytoshi Kusama Claims Attempt To 'Erase' History After Shib...

Core Scientific Seeks $3.3B As It Shifts From Bitcoin Mining...

OpenAI appears to be poaching Coinbase’s marketing team

Brian Armstrong Says Base Is the Best Chain for Trading, Pay...

Polymarket traders win $37K after Paris weather data glitch,...

Visiting India? RBI May Allow Foreign Tourists To Pay Via UP...

Crypto Protocol Umbra Shuts Site To Block Hackers’ Fund Tran...

Popular

ETH Price Prediction: $2,600 Target Within 14 Days as Bulls ...

ServiceNow (NOW) Q3 2024 Earnings Transcript

New York, Illinois Ban Officials From Prediction Markets

Australian Pensions Set to Boost Currency Hedging, Survey Sh...

From Scripts to Swarms: Why AI Is Breaking Traditional Sybil...

Dollar holds near 1-1/2-week high as Iran-US standoff persis...